2013 ACC/AHA cholesterol guideline for reducing cardiovascular risk: What is so controversial?

Current Atherosclerosis Reports

Volumn 16, Issue 6, 2014, Pages

  Robinson, Jennifer G ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cardivoascular disease; Cholesterol; Evidence based; Guideline; Prevention; Risk assessment; Systematic review

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; CHOLESTEROL;

ARTICLE; ATHEROSCLEROSIS; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG EFFICACY; DRUG SAFETY; HEART PROTECTION; HUMAN; LIVER TOXICITY; MEDICAL SOCIETY; MYOPATHY; OUTCOME ASSESSMENT; PATIENT DECISION MAKING; PRACTICE GUIDELINE; PRIMARY PREVENTION; RHABDOMYOLYSIS; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; BLOOD; CARDIOVASCULAR DISEASES; LIFESTYLE; UNITED STATES;

CARDIOVASCULAR DISEASES; CHOLESTEROL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIFE STYLE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; UNITED STATES;

EID: 84896565661     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-014-0413-5     Document Type: Article

References (6)

1. .•• Stone N, Robinson J, Lichtenstein A, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation. 2013. doi:10.1161/1101.cir. 0000437738.0000463853.0000437737a. This is the 2013 U.S cholesterol guideline as discussed in this paper.
2. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust:, 2011: Institute of Medicine;2011.
3. .• Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013. doi:10.1161/1101.cir.0000437741.0000448606.0000437798. This is the 2013 U.S risk assessment guideline discussed in this paper.
4. Ridker PM, Cook NR. Statins: new American guidelines for prevention of cardiovascular disease. Lancet. 2013.
5. .•• Lloyd-Jones D, Goff D, Stone N. Letter to the editor: Statins, risk assessment, and the new American prevention guidelines. Lancet. 2014;383:600-2. The letter addresses criticisms of the Pooled Cohort Equations for ASCVD risk prediction.
6. .• Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. November 12, 2013 2013. This is the 2013 U.S lifestyle guideline discussed in this paper.